João DuarteSenior Editor, Nature Biotechnology, Nature Portfolio
- Nature Portfolio
These technologies have strong potential for therapeutic gene therapy, although it must be said that their application in humans, particularly human embryos, raises considerable ethical questions. ...
These genome editing technologies have the capacity for gene deletion, but its application in humans, particularly human embryos, raises considerable ethical questions. Because of the relatively no...
It's great to see a live collaborative spirit in this highly dynamic research area.
For further reading on the topic, see this feature article by David Owen, staff writer at The New Yorker: